Janux Therapeutics, Inc. (JANX)
13.46
+0.04
(+0.26%)
USD |
NASDAQ |
Mar 03, 16:00
13.53
+0.08
(+0.56%)
After-Hours: 20:00
Janux Therapeutics Research and Development Expense (Annual) : 125.90M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Bristol Myers Squibb Co. | 9.492B |
| Eli Lilly & Co. | 13.34B |
| Ionis Pharmaceuticals, Inc. | 913.18M |
| MannKind Corp. | 66.35M |
| EyePoint Plc | 132.93M |